Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 28, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • miRNA mimicking- a therapeutic approach to obesity genes

Leukocytoclastic vasculitis occurrence after SARS-CoV2 vaccine

Protease inhibitors against severe SARS-CoV-2 infection!

miRNA mimicking- a therapeutic approach to obesity genes
  • BiotechToday
  • World

miRNA mimicking- a therapeutic approach to obesity genes

BioTech Today July 4, 2021July 3, 2021

Kanikah Mehndiratta, MSc, University of Glasgow

A lot of recent approaches to targeting different diseases have been at the transcriptional level where the root cause could be analyzed and/or eliminated. Obesity is one such condition that is being approached through miRNA mimicking as a therapeutic tool in a recent study published in the Molecular Therapy journal. The study predicts mimicking of miRNA to be a guide for the drug development process against obesity. 

miRNAs as potential therapeutic targets:

miRNAs are a type of single-stranded, non-coding mRNAs that prove useful in the regulation of gene expression. From primary to precursors, and finally, a mature miRNA mostly interacts with the 3’ UTR of its target mRNA, mainly repressing the transcriptional function of the associated gene. It may interact with the 5’ UTR, the promoter region, or even the coding sequences. It might also be involved in translational activation, where the interaction is believed to be dependent on a lot of different factors such as location, abundancy, affinity, and the target mRNAs. Due to this dynamic regulatory role during transcription, especially in metabolic processes, they are being considered as potential therapeutic targets for various conditions.

Targeting obesity through miRNA mimicking:

The comorbidities associated with obesity such as insulin resistance, high blood pressure, stroke, cardiovascular diseases, sleep apnoea, etc. are reported to be developing due to dysregulation of many different miRNAs in white adipose tissues and liver muscles. The particular miRNA focused on in this Spain study is the miR-21 in the white adipose tissues. The expression level of the normal miRNA in diseased conditions was analyzed to predict the effect of a mimic in the functionality of the tissues and consider its potential application in therapy for obesity. The miR-21 levels were lower in normal-weight mice and humans in comparison to a diabetic obese sample. The mimic used was also shown to affect the functionality of the adipose tissues and was observed to significantly enhance gene expression in thermogenesis and browning by directly interfering with the activity of the RNA-induced silencing complex leading to a gain of function and increasing metabolic rate.

Results:

The artificial mi-RNA mimic in-vivo treatment, also called the miRNA replacement therapy, blocked weight gain by interfering with the p53, TGFβ1 signalling pathways that were causing metabolic activity enhancement. This study thus suggested a therapeutic potential to manage obesity and associated comorbidities.

Also read: Whitefly hijacks a plant gene- Let’s learn how is that possible?

References:

1. Lhamyani, S., Gentile, A-M., Giráldez-Pérez, R. M., et al. (2020). miR-21 blocks obesity in mice: a potential therapy for humans. medRxiv. https://doi.org/10.1101/2020.10.27.20219915

2. O’Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in endocrinology, 9, 402. https://doi.org/10.3389/fendo.2018.00402

About author:

Kanikah Mehndiratta is an avid researcher in the field of Genetics with a background in Biotechnology. She is a postgraduate from the University of Glasgow in their Medical Genetics and Genomics program. Currently, based in Chandigarh as a Scientific Writer, she involves herself mainly in projects related to neurological disorders. Apart from academics, she likes to read novels, travel and is involved in volunteer work mostly.

LinkedIn profile- https://www.linkedin.com/in/kanikah-mehndiratta-301830171

Other articles-

1.https://bioxone.in/news/worldnews/transcriptomic-analysis-of-etiology-behind-fatality-in-hiv-patients/

2. https://bioxone.in/news/worldnews/iga-virus-immune-complex-neutrophils-trap-for-sars-cov-2/ 3.https://bioxone.in/news/worldnews/first-ever-genomic-analysis-on-the-african-swine-fever-virus/

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged artificial miRNA duplexes mimicking miRNA mRNA Obesity RNA-induced silencing complex white adipose tissues

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Protease inhibitors against severe SARS-CoV-2 infection!

BioTech Today July 4, 2021

Shrestha Dutta, Amity University Kolkata SARS-CoV2 belongs to the Coronaviridae family in the Nidovirales order. Coronavirus resembles crown-like spikes on the external surface of the viral envelope. CoVsare miniature in size (65–125 nm in measurement) and contain a single-stranded (+)-RNA as the genetic material of 26-32kb long. Coronaviruses are generally grouped into alpha (a), beta […]

Related Post

  • BiotechToday
  • World

Organoid Technology helps to beat COVID-19

bioxone May 31, 2021May 31, 2021

Sagnik Nag, Amity University, Kolkata Virologists have infected many miniature organs with SARS-CoV-2, to learn how the virus wreaks havoc and the means to prevent it. Chen, a stem-cell biologist at Weill Cornell Medicine in New York City, and her team had nurtured them from clumps of human cells, adding nutrients every occasional day as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Ribovore: An rRNA sequence validation system for GenBank submissions

BioTech Today August 15, 2021August 15, 2021

Sayak Banerjee, Amity University Kolkata In the year 1977, the Archaebacteria or Archaea, the third domain of life separate from Bacteria and Eukaryota, was proposed by Carl Woese and George Fox. They had analyzed small subunit ribosomal RNA ( SSU rRNA) oligonucleotide fragments from 13 microbes before establishing this proposal. In the late 1980s, the use of SSU rRNA to describe […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Interference of human microbiome with cancer therapeutics

BioTech Today August 21, 2021August 20, 2021

Kanikah Mehndiratta, MSc, University of Glasgow Human microbiome constitutes various microorganisms and their genomes, residing on the skin or inside organ systems. Inside the body, these microbes are known to be involved in many intricate metabolic pathways. This automatically gives them an opportunity to interfere in different diseases and their treatments. Devising successful therapeutics against […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy